Showing 2461-2470 of 19324 results for "".
How Does Healthcare Policy Impact Physicians?
https://reachmd.com/programs/focus-on-public-health-policy/how-does-healthcare-policy-impact-physicians/3683/Who controls our professional lives? The policymakers do, of course. Join host Dr. Bill Rutenberg and his guest Dr. Aaron Carroll, associate professor of pediatrics and director of the Center for Health Policy and Professionalism Research at the Indiana University School of Medicine as they exploreTreating & Preventing Pediatric Overuse Injuries
https://reachmd.com/programs/clinicians-roundtable/treating-preventing-pediatric-overuse-injuries/3275/More and more children are presenting with overuse injuries. What is happening at the cellular level and how do their bodies repair? Dr. Paul Stricker, board certified in both pediatrics and sports medicine joins host Dr. Bill Rutenberg to discuss pediatric overuse injuries. They discuss the need foINTEGUMENT-OLE and What’s Next for Pediatric AD
https://reachmd.com/series/skin-minute/integument-ole-study/56899/Pediatric dermatologist Larry Eichenfield, MD, talks about the INTEGUMENT-OLE study data and the impact of the roflumilast cream 0.05% (Zoryve) on the treatment of mild-to-moderate atopic dermatitis in children aged 2 to 5 years.Infectious Disease Care Through the Lens of Patient Context
https://reachmd.com/programs/clinicians-roundtable/infectious-disease-patient-context/48843/How do lived experience, community dynamics, and socioeconomic realities shape infectious disease risk and patient decision making? Dr. Darilyn Moyer, Executive Vice President and Chief Executive Officer of the American College of Physicians, explains how incorporating patient context into communicaOctane Aesthetics Tech Forum: Clinical Insights Shaping 2026
https://reachmd.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-clinical-insights-shaping-2026/54712/Patricia Walker, MD, PhD, Founder and President of Walker Consulting, dives into key insights from the Octane Aesthetics Tech Forum and how they may influence the industry in 2026.Unlocking the Potential of TYK2 Inhibitors in Plaque Psoriasis
https://reachmd.com/programs/frontlines-psoriasis/tyk2-inhibitors-plaque-psoriasis-potential/39952/With high selectivity, durable response, and once-daily dosing, next-generation TYK2 inhibitors offer a promising oral option for patients with moderate-to-severe plaque psoriasis. Ryan Quigley sits down with Dr. Christopher Bunick, Associate Professor of Dermatology and Translational BiomedNavigating Genetic Testing in Kidney Transplants: Clinical and Ethical Issues
https://reachmd.com/programs/clinicians-roundtable/navigating-genetic-testing-in-kidney-transplants-clinical-and-ethical-issues/37222/Genetic testing is becoming an essential tool in kidney transplant evaluation and living donor screening, with APOL1 testing gaining traction for identifying post-donation risk. However, this evolving practice raises complex ethical and logistical challenges, as discussed by Dr. Elisa Gordon at theBridging Gaps in Kidney Care: How to Improve Referrals, Transitions, and Coordination
https://reachmd.com/programs/clinicians-roundtable/bridging-gaps-in-kidney-care-how-to-improve-referrals-transitions-and-coordination/37224/From delayed referrals to fragmented care, health systems face several barriers to delivering timely, coordinated kidney care. That’s why Dr. Mallika Mendu joins us to highlight three critical areas for improvement: promoting early, guideline-based referrals from primary care, enhancing coordinationAdvancing MPE Diagnosis and Prognosis: Clinical Value of Biomarker Integration
https://reachmd.com/programs/clinicians-roundtable/advancing-mpe-diagnosis-and-prognosis-clinical-value-of-biomarker-integration/35660/Cytology via thoracentesis remains the first-line approach for diagnosing malignant pleural effusion (MPE), yet its sensitivity is limited. leaving many patients undiagnosed or delayed in treatment. In this expert-led discussion, Dr. David Feller-Kopman explores the limitations of current diaInnovations in IgAN Care: Addressing Challenges with Therapeutic Advances
https://reachmd.com/programs/clinicians-roundtable/innovations-in-igan-care-addressing-challenges-with-therapeutic-advances/37217/The available treatment options and even the current guidelines for the management of IgA nephropathy (IgAN) come with several limitations. Fortunately, new therapies are on the horizon that can help us address those challenges and slow disease progression in IgAN. Here with Dr. Charles Turck to dis